PL1794190T3 - Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii - Google Patents

Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii

Info

Publication number: PL1794190T3
Authority: PL; Poland
Prior art keywords: epitopes; tumour; present; immunotherapeutic methods; relates
Prior art date: 2004-10-02

Application number

PL05778354T

Other languages

English (en)

Inventor

Hans-Georg Rammensee

Toni Weinschenk

Jörn Dengjel

Original Assignee

Immatics Biotechnologies Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-02

Filing date

2005-09-09

Publication date

2010-01-29

2005-09-09 Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh

2010-01-29 Publication of PL1794190T3 publication Critical patent/PL1794190T3/pl

Links

206010028980 Neoplasm Diseases 0.000 title abstract 4
230000001024 immunotherapeutic effect Effects 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000002163 immunogen Effects 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
230000000259 anti-tumor effect Effects 0.000 abstract 2
230000028993 immune response Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
229960005486 vaccine Drugs 0.000 abstract 2
208000008839 Kidney Neoplasms Diseases 0.000 abstract 1
206010038389 Renal cancer Diseases 0.000 abstract 1
239000008186 active pharmaceutical agent Substances 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
238000009169 immunotherapy Methods 0.000 abstract 1
201000010982 kidney cancer Diseases 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL05778354T 2004-10-02 2005-09-09 Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii PL1794190T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04023546A EP1642905B1 (en)	2004-10-02	2004-10-02	Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
EP05778354A EP1794190B9 (en)	2004-10-02	2005-09-09	Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
PCT/EP2005/009719 WO2006037421A2 (en)	2004-10-02	2005-09-09	Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes

Publications (1)

Publication Number	Publication Date
PL1794190T3 true PL1794190T3 (pl)	2010-01-29

Family

ID=34926825

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL04023546T PL1642905T3 (pl)	2004-10-02	2004-10-02	Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy
PL05778354T PL1794190T3 (pl)	2004-10-02	2005-09-09	Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL04023546T PL1642905T3 (pl)	2004-10-02	2004-10-02	Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy

Country Status (11)

Country	Link
US (1)	US8067529B2 (pl)
EP (2)	EP1642905B1 (pl)
JP (2)	JP2008514208A (pl)
AT (2)	ATE421533T1 (pl)
AU (1)	AU2005291660B2 (pl)
CA (1)	CA2583065A1 (pl)
DE (2)	DE602004019215D1 (pl)
ES (2)	ES2319286T3 (pl)
PL (2)	PL1642905T3 (pl)
SI (2)	SI1642905T1 (pl)
WO (1)	WO2006037421A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0609121D0 (en)	2006-05-09	2006-06-21	Univ Birmingham	Peptide Therapy
US20090004213A1 (en) *	2007-03-26	2009-01-01	Immatics Biotechnologies Gmbh	Combination therapy using active immunotherapy
CA2817054C (en)	2007-07-27	2017-02-28	Immatics Biotechnologies Gmbh	Composition of tumour-associated peptides and related anti-cancer vaccine
TW200932260A (en) *	2007-11-28	2009-08-01	Oncotherapy Science Inc	STAT3 epitope peptides
TW201000119A (en) *	2008-06-10	2010-01-01	Oncotherapy Science Inc	MYBL2 epitope peptides and vaccines containing the same
EP2172211B1 (en) *	2008-10-01	2014-12-03	Immatics Biotechnologies GmbH	Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
AU2016204708B2 (en) *	2008-10-01	2018-02-22	Immatics Biotechnologies Gmbh	Novel immunotherapy against several tumors including neuronal and brain tumors
CA2743361C (en) *	2008-10-06	2021-05-25	Neil R. Cashman	Methods and systems for predicting misfolded protein epitopes
US9023802B2 (en)	2009-12-14	2015-05-05	Immatics Biotechnologies Gmbh	HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
GB201004575D0 (en)	2010-03-19	2010-05-05	Immatics Biotechnologies Gmbh	Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
GB201009222D0 (en)	2010-06-02	2010-07-21	Immatics Biotechnologies Gmbh	Improved cancer therapy based on tumour associated antigens derived from cyclin D1
MX2013006758A (es)	2010-12-14	2013-08-01	Immatics Biotechnologies Gmbh	Peptidos de union a hla derivados de moleculas antigenicas asociadas a la prostata y metodos de uso de los mismos.
CA2903817A1 (en)	2013-03-12	2014-10-09	Institute of Arthritis Research, LLC	Immunologically active polypeptide
CN110041403B (zh)	2013-08-05	2023-03-10	伊玛提克斯生物技术有限公司	针对多种肿瘤例如包括nsclc在内的肺癌的新型免疫疗法
ES2902835T3 (es)	2014-01-09	2022-03-30	Hadasit Med Res Service	Composiciones celulares mejoradas y métodos para la terapia contra el cáncer
EP3122375B1 (en) *	2014-03-28	2021-03-03	University of Washington through its Center for Commercialization	Breast and ovarian cancer vaccines
ES2749073T3 (es) *	2014-04-01	2020-03-19	Inst Nat Sante Rech Med	Un péptido donante aislado derivado de MHC y su uso
WO2015150492A2 (en) *	2014-04-01	2015-10-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	An isolated donor mhc-derived peptide and uses thereof
NL2014935B1 (en)	2015-06-08	2017-02-03	Applied Immune Tech Ltd	T cell receptor like antibodies having fine specificity.
HK1254866A1 (zh) *	2015-06-25	2019-07-26	Immatics Biotechnologies Gmbh	用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物
PH12022551111A1 (en) *	2015-10-05	2023-08-23	Immatics Biotechnologies Gmbh	Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
GB201520550D0 (en)	2015-11-23	2016-01-06	Immunocore Ltd & Adaptimmune Ltd	Peptides
GB201607535D0 (en) *	2016-04-29	2016-06-15	Immunocore Ltd & Adaptimmune Ltd	Peptides
GB201520568D0 (en)	2015-11-23	2016-01-06	Immunocore Ltd	Peptides
GB201521746D0 (en)	2015-12-10	2016-01-27	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
CN109937364B (zh) *	2016-06-27	2022-12-02	朱诺治疗学股份有限公司	Mhc-e限制性表位、结合分子以及相关方法和用途
US11834487B2 (en)	2018-02-12	2023-12-05	Hadasit Medical Research Services & Development Ltd.	Modulation of SLAMF6 splice variants for cancer therapy
JP7609775B2 (ja) *	2018-12-14	2025-01-07	インセルム（インスティチュートナショナルデラサンテエデラリシェルシェメディカル）	単離されたＭＨＣ由来ヒトペプチドおよびＣＤ８＋ＣＤ４５ＲＣｌｏｗＴｒｅｇの抑制機能を刺激し、かつ活性化するためのその使用
JP2022531095A (ja) *	2019-04-17	2022-07-06	コディアックバイオサイエンシーズ，インコーポレイテッド	エキソソーム及びａａｖの組成物
IL267614A (en)	2019-06-24	2019-09-26	Lotem Michal	Nucleic acids to modulate SLAMF6 isoforms
EP4304632A2 (en) *	2021-03-11	2024-01-17	Mnemo Therapeutics	Tumor neoantigenic peptides
WO2025069022A1 (en) *	2023-09-28	2025-04-03	Hadasit Medical Research Services And Development Ltd.	Immunomodulating peptides and uses thereof
US20250216401A1 (en) *	2024-01-03	2025-07-03	The Terasaki Innovation Center	Method of detecting human leukocyte antigens (hla)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0584264A1 (en) *	1991-05-16	1994-03-02	Cold Spring Harbor Laboratory	D-type cyclin and uses related thereto
AUPM322393A0 (en)	1993-12-24	1994-01-27	Austin Research Institute, The	Mucin carbohydrate compounds and their use in immunotherapy
US5912167A (en) *	1995-06-06	1999-06-15	Wisconsin Alumni Research Foundation	Autocatalytic cleavage site and use thereof in a protein expression vector
ES2203782T3 (es)	1996-01-17	2004-04-16	Imperial College Innovations Limited	Inmunoterapia que utiliza linfocitos t citotoxicos (ctl).
GB9823897D0 (en) *	1998-11-02	1998-12-30	Imp College Innovations Ltd	Immunotherapeutic methods and molecules
EP1434860A2 (en) *	2001-09-28	2004-07-07	Incyte Genomics, Inc.	Enzymes
US20030194704A1 (en) *	2002-04-03	2003-10-16	Penn Sharron Gaynor	Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
DE10225144A1 (de) *	2002-05-29	2003-12-18	Immatics Biotechnologies Gmbh	An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP1369482A1 (en) *	2002-06-07	2003-12-10	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Target genes for the diagnosis and treatment of cancer
EP1869224A4 (en)	2005-04-15	2009-11-18	Oncomethylome Sciences Inc	METHYLATION MARKERS FOR THE DIAGNOSIS AND TREATMENT OF CANCERS

2004
- 2004-10-02 DE DE602004019215T patent/DE602004019215D1/de not_active Expired - Lifetime
- 2004-10-02 AT AT04023546T patent/ATE421533T1/de active
- 2004-10-02 PL PL04023546T patent/PL1642905T3/pl unknown
- 2004-10-02 SI SI200431004T patent/SI1642905T1/sl unknown
- 2004-10-02 EP EP04023546A patent/EP1642905B1/en not_active Expired - Lifetime
- 2004-10-02 ES ES04023546T patent/ES2319286T3/es not_active Expired - Lifetime
2005
- 2005-09-09 JP JP2007533893A patent/JP2008514208A/ja active Pending
- 2005-09-09 EP EP05778354A patent/EP1794190B9/en not_active Expired - Lifetime
- 2005-09-09 SI SI200530786T patent/SI1794190T1/sl unknown
- 2005-09-09 DE DE602005015990T patent/DE602005015990D1/de not_active Expired - Lifetime
- 2005-09-09 PL PL05778354T patent/PL1794190T3/pl unknown
- 2005-09-09 AT AT05778354T patent/ATE439375T1/de active
- 2005-09-09 US US11/664,627 patent/US8067529B2/en not_active Expired - Fee Related
- 2005-09-09 ES ES05778354T patent/ES2328945T3/es not_active Expired - Lifetime
- 2005-09-09 AU AU2005291660A patent/AU2005291660B2/en not_active Ceased
- 2005-09-09 CA CA002583065A patent/CA2583065A1/en not_active Abandoned
- 2005-09-09 WO PCT/EP2005/009719 patent/WO2006037421A2/en not_active Ceased
2011
- 2011-04-21 JP JP2011094758A patent/JP2011200231A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO2006037421A2 (en)	2006-04-13
US8067529B2 (en)	2011-11-29
EP1794190B1 (en)	2009-08-12
SI1794190T1 (sl)	2009-12-31
ES2328945T3 (es)	2009-11-19
DE602005015990D1 (de)	2009-09-24
EP1794190B9 (en)	2010-05-19
DE602004019215D1 (de)	2009-03-12
JP2008514208A (ja)	2008-05-08
JP2011200231A (ja)	2011-10-13
US20090317428A1 (en)	2009-12-24
AU2005291660A1 (en)	2006-04-13
ATE439375T1 (de)	2009-08-15
PL1642905T3 (pl)	2009-04-30
EP1642905A1 (en)	2006-04-05
EP1642905B1 (en)	2009-01-21
SI1642905T1 (sl)	2009-04-30
CA2583065A1 (en)	2006-04-13
ES2319286T3 (es)	2009-05-06
EP1794190A2 (en)	2007-06-13
AU2005291660B2 (en)	2010-02-18
WO2006037421A3 (en)	2006-06-29
ATE421533T1 (de)	2009-02-15

Publication	Publication Date	Title
PL1642905T3 (pl)	2009-04-30	Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy
EA200800677A1 (ru)	2008-08-29	Опухолеассоциированные пептиды, беспорядочно связывающиеся с молекулами класса ii человеческого лейкоцитарного антигена (hla)
PL1760089T3 (pl)	2010-03-31	Peptydy towarzyszące nowotworom, wiążące się z cząsteczkami klasy I i II antygenów ludzkich leukocytów (HLA) i związana z nimi szczepionka przeciwnowotworowa